Faron Pharmaceuticals Oy Holdings in Company (5889G)
30 May 2017 - 11:06PM
UK Regulatory
TIDMFARN
RNS Number : 5889G
Faron Pharmaceuticals Oy
30 May 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
-------------------------------------------------------------------------------------------------
1. Identity of the issuer or Faron Pharmaceuticals Oy
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------- ------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------ -----------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------ -----------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------ -----------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------ -----------------------------------
Other (please
specify):
---------------------------------------------------------- -----------------------------------
3. Full name of person(s) City Financial Investment
subject to the Company Limited, acting as
notification obligation: Investment Manager and Authorised
(iii) Corporate Director of the
City Financial Absolute Equity
Fund
----------------------------------------------------------- ------------------------------------
4. Full name of shareholder(s) BNY Mellon Trust and Depositary
(if different from 3.):(iv) as Trustee to the City Financial
Absolute Equity Fund
----------------------------------------------------------- ------------------------------------
5. Date of the transaction 26 May 2017
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ------------------------------------
6. Date on which issuer 30 May 2017
notified:
----------------------------------------------------------- ------------------------------------
7. Threshold(s) that is/are
crossed or
reached: (vi, vii) 4%
----------------------------------------------------------- ------------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if
possible
using
the ISIN
CODE
----------- ---------------------------------- ---------------------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
----------- ---------------- ---------------- -------------- -------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
----------- ------------ ------------ -------------- ------------ ------------ ------------ -----------
1,105,530 1,140,530 1,140,530 1,105,530 1,105,530 0 3.98% 0
----------- ---------------- ---------------- -------------- ------------ ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
--------------- -------------- -------------------------------- ---------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
------------- -------------- -------------- ---------------- ---------------------------- -----------------------
Nominal Delta
------------- -------------- -------------- ---------------- ---------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
1,105,530 3.98%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
------------------------------------------------------------------------------
The voting rights are managed and controlled by City
Financial Investment Company Limited, Investment manager
and ACD to the City Financial Absolute Equity Fund.
Proxy Voting:
------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- ---------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------------------- ---------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- ---------------
13. Additional information:
------------------------------------------------------------- ---------------
14. Contact name: Ben Ellenbogen
------------------------------------------------------------- ---------------
15. Contact telephone number: 0207 451 9600
------------------------------------------------------------- ---------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLXBLFXDEFBBBZ
(END) Dow Jones Newswires
May 30, 2017 09:06 ET (13:06 GMT)
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From Apr 2024 to May 2024
Faron Pharmaceuticals Oy (LSE:FARN)
Historical Stock Chart
From May 2023 to May 2024
